| Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ... Cancer research 59 (22), 5830-5835, 1999 | 3643 | 1999 |
| AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer ES Antonarakis, C Lu, H Wang, B Luber, M Nakazawa, JC Roeser, ... New England Journal of Medicine 371 (11), 1028-1038, 2014 | 2939 | 2014 |
| Inflammation in prostate carcinogenesis AM De Marzo, EA Platz, S Sutcliffe, J Xu, H Grönberg, CG Drake, Y Nakai, ... Nature Reviews Cancer 7 (4), 256-269, 2007 | 2103 | 2007 |
| Mutations of the VHL tumour suppressor gene in renal carcinoma JR Gnarra, K Tory, Y Weng, L Schmidt, MH Wei, H Li, F Latif, S Liu, ... Nature genetics 7 (1), 85-90, 1994 | 2077 | 1994 |
| REVEL: an ensemble method for predicting the pathogenicity of rare missense variants NM Ioannidis, JH Rothstein, V Pejaver, S Middha, SK McDonnell, ... The American Journal of Human Genetics 99 (4), 877-885, 2016 | 2075 | 2016 |
| Dd3:: A new prostate-specific gene, highly overexpressed in prostate cancer MJG Bussemakers, A Van Bokhoven, GW Verhaegh, FP Smit, ... Cancer research 59 (23), 5975-5979, 1999 | 1580 | 1999 |
| The evolutionary history of lethal metastatic prostate cancer G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ... Nature 520 (7547), 353-357, 2015 | 1508 | 2015 |
| Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ... Cancer research 69 (1), 16-22, 2009 | 1330 | 2009 |
| E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas JR Graff, JG Herman, RG Lapidus, H Chopra, R Xu, DF Jarrard, ... Cancer research 55 (22), 5195-5199, 1995 | 1128 | 1995 |
| Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. WH Lee, RA Morton, JI Epstein, JD Brooks, PA Campbell, GS Bova, ... Proceedings of the National Academy of Sciences 91 (24), 11733-11737, 1994 | 1094 | 1994 |
| Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search JR Smith, D Freije, JD Carpten, H Grönberg, J Xu, SD Isaacs, ... Science 274 (5291), 1371-1374, 1996 | 1058 | 1996 |
| Frequent Inactivation of PTEN/MMAC1 in Primary Prostate Cancer P Cairns, K Okami, S Halachmi, N Halachmi, M Esteller, JG Herman, ... Cancer research 57 (22), 4997-5000, 1997 | 1033 | 1997 |
| Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 J Gudmundsson, P Sulem, A Manolescu, LT Amundadottir, ... Nature genetics 39 (5), 631-637, 2007 | 1016 | 2007 |
| DPC4 Gene in Various Tumor Types M Schutte, RH Hruban, L Hedrick, KR Cho, GM Nadasdy, CL Weinstein, ... Cancer research 56 (11), 2527-2530, 1996 | 995 | 1996 |
| Hereditary prostate cancer: epidemiologic and clinical features BS Carter, GS Bova, TH Beaty, GD Steinberg, B Childs, WB Isaacs, ... The Journal of urology 150 (3), 797-802, 1993 | 958 | 1993 |
| Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression YE Whang, X Wu, H Suzuki, RE Reiter, C Tran, RL Vessella, JW Said, ... Proceedings of the National Academy of Sciences 95 (9), 5246-5250, 1998 | 896 | 1998 |
| α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer J Luo, S Zha, WR Gage, TA Dunn, JL Hicks, CJ Bennett, CM Ewing, ... Cancer research 62 (8), 2220-2226, 2002 | 832 | 2002 |
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours P Cairns, TJ Polascik, Y Eby, K Tokino, J Califano, A Merlo, L Mao, ... Nature genetics 11 (2), 210-212, 1995 | 831 | 1995 |
| Germline mutations in HOXB13 and prostate-cancer risk CM Ewing, AM Ray, EM Lange, KA Zuhlke, CM Robbins, WD Tembe, ... New England Journal of Medicine 366 (2), 141-149, 2012 | 828 | 2012 |
| Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer R Umbas, JA Schalken, TW Aalders, BS Carter, HFM Karthaus, ... Cancer research 52 (18), 5104-5109, 1992 | 826 | 1992 |
